Acta Academiae Medicinae Sinica
Acta Academiae Medicinae Sinica ›› 2018, Vol. 40 ›› Issue (3): 421-426.doi: 10.3881/j.issn.1000-503X.2018.03.022
• Review Articles • Previous Articles Next Articles
NAN Min,LI Wenhui(
)
Received:2017-03-13
Online:2018-06-30
Published:2018-07-05
CLC Number:
NAN Min, LI Wenhui. Role of Paradoxical Hypersecretion of Glucagon in the Pathogenesis of Type 2 Diabetes Mellitus[J].Acta Academiae Medicinae Sinica, 2018, 40(3): 421-426.
| [1] | WHO Mortality Database. Geneva:World Health Organization[EB/OL]. [ 2016- 01- 12]. . |
| [2] |
徐瑜, 毕宇芳, 王卫庆 , 等. 中国成人糖尿病流行与控制现状—2010年中国慢病监测暨糖尿病专题调查报告解读[J]. 中华内分泌代谢杂志, 2014,30(3):184-186. DOI: 10. 3760/cma.j.issn.1000-6699.2014.03.002.
doi: 10. 3760/cma.j.issn.1000-6699.2014.03.002 |
| [3] |
Yang W, Lu J, Weng J , et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010,362(12):1090-1101. DOI: 10.1056/NEJMoa0908292.
doi: 10.1056/NEJMoa0908292 |
| [4] |
Unger RH, Orci L . The essential role of glucagon in the pathogenesis of diabetes mellitus[J]. Lancet, 1975,1(7897):14-16. DOI: 10.1016/S0140-6736 (75)92954-2.
doi: 10.1016/S0140-6736 (75)92954-2 pmid: 46337 |
| [5] |
Bagger JI . Physiological and pathophysiological aspects of incretin hormones and glucagon[J]. Dan Med J, 2017,64(1):B5331.
pmid: 28007055 |
| [6] |
Kelly C , McClenaghan NH,Flatt PR. Role of islet structure and cellular interactions in the control of insulin secretion[J]. Islets, 2011,3(2):41-47.
doi: 10.4161/isl.3.2.14805 pmid: 21372635 |
| [7] |
Moon JS, Won KC . Pancreatic α-cell dysfunction in type 2 diabetes:old kids on the block[J]. Diabetes Metab J, 2015,39(1):1-9. DOI: 10.4093/dmj.2015.39. 1.1.
doi: 10.4093/dmj.2015.39. 1.1 pmid: 25729706 |
| [8] |
Walker JN, Ramracheya R, Zhang Q , et al. Regulation of glucagon secretion by glucose:paracrine,intrinsic or both[J]. Diabetes Obes Metab, 2011,13(Suppl 1):95-105. DOI: 10.1111/j.1463-1326.2011.01450.x.
doi: 10.1111/j.1463-1326.2011.01450.x pmid: 21824262 |
| [9] |
Fridlyand LE, Philipson LH . A computational systems analysis of factors regulating α cell glucagon secretion[J]. Islets, 2012,4(4):262-283. DOI: 10. 4161/isl.22193.
doi: 10. 4161/isl.22193 pmid: 3496652 |
| [10] |
Rocha DM, Faloona GR, Unger RH . Glucagon-stimulating activity of 20 amino acids in dogs[J]. J Clin Invest, 1972,51(9):2346-2351.DOI: 10.1172/JCI107046.
doi: 10.1172/JCI107046 pmid: 4639019 |
| [11] |
Wewer Albrechtsen NJ, Kuhre RE, Windel?v JA , et al. Dynamics of glucagon secretion in mice and rats revealed using a validated sandwich ELISA for small sample volumes[J]. Am J Physiol Endocrinol Metab, 2016,311(2):E302-E309. DOI: 10.1152/ajpendo.00119.2016.
doi: 10.1152/ajpendo.00119.2016 pmid: 27245336 |
| [12] |
Quek R, Bi X, Henry CJ . Impact of protein-rich meals on glycaemic response of rice[J]. Br J Nutr, 2016,115(7):1194-1201. DOI: 10.1017/S0007114515005 498.
doi: 10.1017/S0007114515005 498 pmid: 26856623 |
| [13] |
Joffe YT, Collins M, Goedecke JH . The relationship between dietary fatty acids and inflammatory genes on the obese phenotype and serum lipids[J]. Nutrients, 2013,5(5):1672-1705. DOI: 10.3390/nu5051672.
doi: 10.3390/nu5051672 pmid: 3708344 |
| [14] |
Guardado-Mendoza R, Jimenez-Ceja L, Majluf-Cruz A , et al. Impact of obesity severity and duration on pancreatic β-and α-cell dynamics in normoglycemic non-human primates[J]. Int J Obes (Lond), 2013,37(8):1071-1078. DOI: 10.1038/ijo.2012.205.
doi: 10.1038/ijo.2012.205 pmid: 23229736 |
| [15] |
Barnes TM, Otero YF, Elliott AD , et al. Interleukin-6 amplifies glucagon secretion:coordinated control via the brain and pancreas[J]. Am J Physiol Endocrinol Metab, 2014,307(10):E896-E905. DOI: 10.1152/ajpendo.00343. 2014.
doi: 10.1152/ajpendo.00343. 2014 pmid: 25205821 |
| [16] |
李文慧, 肖新华, 于康 , 等. 短期高脂饮食对中国汉族男性2型糖尿病患者糖脂代谢的影响[J]. 中国医学科学院学报, 2008,30(4):509-515. DOI: 10.3881/j.issn.1000-503x.2008.04.029.
doi: 10.3881/j.issn.1000-503x.2008.04.029 |
| [17] |
Merino B, Alonso-Magdalena P, Lluesma M , et al. Pancreatic alpha-cells from female mice undergo morphofunctional changes during compensatory adaptations of the endocrine pancreas to diet-induced obesity[J]. Sci Rep, 2015,5(1):11622-11634. DOI: 10.1038/srep11622.
doi: 10.1038/srep11622 pmid: 26108563 |
| [18] |
Ugleholdt R . Glucose-dependent insulinotropic polypeptide (GIP):from prohormone to actions in endocrine pancreas and adipose tissue[J]. Dan Med Bull, 2011,58(12):B4368.
doi: 10.1136/bmj.d7459 pmid: 22142579 |
| [19] |
Cho YM, Kieffer TJ . K-cells and glucose-dependent insulinotropic polypeptide in health and disease[J]. Vitam Horm, 2010,84:111-150. DOI: 10.1016/B978-0-12-381517-0.00004-7.
doi: 10.1016/B978-0-12-381517-0.00004-7 |
| [20] |
Meier JJ, Gallwitz B, Siepmann N , et al. Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia[J]. Diabetologia, 2003,46(6):798-801. DOI: 10.1007/s00125-003-1103-y.
doi: 10.1007/s00125-003-1103-y pmid: 12764578 |
| [21] |
Christensen MB , Glucose-dependent insulinotropic polypeptide:effects on insulin and glucagon secretion in humans[J]. Dan Med J, 2016,63(4):B5230.
pmid: 27034187 |
| [22] |
Jones BJ, Tan T, Bloom SR . Minireview:glucagon in stress and energy homeostasis[J]. Endocrinology, 2012,153(3):1049-1054. DOI: 10.1210/en.2011-1979.
doi: 10.1210/en.2011-1979 pmid: 22294753 |
| [23] |
Elliott AD, Ustione A, Piston DW . Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic α-cell by lowering cAMP[J]. Am J Physiol Endocrinol Metab, 2015,308(2):E130-E143. DOI: 10.1152/ajpendo.00344.2014.
doi: 10.1152/ajpendo.00344.2014 pmid: 25406263 |
| [24] |
Alma?a J, Molina J, Menegaz D , et al. Human beta cells produce and release serotonin to inhibit glucagon secretion from alpha cells[J]. Cell Rep, 2016,17(12):3281-3291. DOI: 10.1016/j.celrep.2016.11.072.
doi: 10.1016/j.celrep.2016.11.072 pmid: 5217294 |
| [25] |
Kawamori D, Kurpad AJ, Hu J , et al. Insulin signaling in alpha cells modulates glucagon secretion in vivo[J]. Cell Metab, 2009,9(4):350-361. DOI: 10.1016/j.cmet.2009.02.007.
doi: 10.1016/j.cmet.2009.02.007 pmid: 2694613 |
| [26] |
Yu R . Pancreatic α-cell hyperplasia:facts and myths[J]. J Clin Endocrinol Metab, 2014,99(3):748-756. DOI: 10.1210/jc.2013-2952.
doi: 10.1210/jc.2013-2952 pmid: 24285676 |
| [27] |
Ferrannini E, Muscelli E, Natali A , et al. Association of fasting glucagon and proinsulin concentrations with insulin resistance[J]. Diabetologia, 2007,50(11):2342-2347. DOI: 10.1007/s00125-007-0806-x.
doi: 10.1007/s00125-007-0806-x pmid: 17846745 |
| [28] |
Morisset J . Somatostatin:One of the rare multifunctional inhibitors of mammalian species[J]. Pancreas, 2017,46(1):8-18. DOI: 10.1097/MPA.0000000000000716.
doi: 10.1097/MPA.0000000000000716 |
| [29] |
Yoshimoto Y, Fukuyama Y, Horio Y , et al. Somatostatin induces hyperpolarization in pancreatic islet alpha cells by activating a G protein-gated K +channel [J]. FEBS Lett, 1999,444(2-3):265-269.
doi: 10.1016/S0014-5793(99)00076-9 pmid: 10050772 |
| [30] |
Gylfe E . Glucose control of glucagon secretion-‘There’s a brand-new gimmick every year’[J]. Ups J Med Sci, 2016,121(2):120-132. DOI: 10.3109/03009734. 2016.1154905.
doi: 10.3109/03009734. 2016.1154905 pmid: 4900067 |
| [31] |
Ludvigsen E, Carlsson C, Tiensuu Janson E , et al. Somatostatin receptor 1-5;expression profiles during rat development[J]. Ups J Med Sci, 2015,120(3):157-168.DOI: 10.3109/03009734.2015.1035413.
doi: 10.3109/03009734.2015.1035413 pmid: 2592639015 |
| [32] |
Bodnaruc AM, Prud’homme D, Blanchet R , et al. Nutritional modulation of endogenous glucagon-like peptide-1 secretion:a review[J]. Nutr Metab, 2016,13(1):92-107. DOI: 10.1186/s12986-016-0153-3.
doi: 10.1186/s12986-016-0153-3 pmid: 5148911 |
| [33] |
Nadkarni P, Chepurny OG, Holz GG . Regulation of glucose homeostasis by GLP-1[J]. Prog Mol Biol Transl Sci, 2014,121:23-65. DOI: 10.1016/B978-0-12-800101-1.00002-8.
doi: 10.1016/B978-0-12-800101-1.00002-8 |
| [34] |
Calanna S, Christensen M, Holst JJ , et al. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus:systematic review and meta-analyses of clinical studies[J]. Diabetologia, 2013,56(5):965-972. DOI: 10.1007/s00125-013-2841-0.
doi: 10.1007/s00125-013-2841-0 |
| [35] |
Wewer Albrechtsen NJ, Kuhre RE, Pedersen J , et al. The biology of glucagon and the consequences of hyperglucagonemia[J]. Biomark Med, 2016,10(11):1141-1151.DOI: 10.2217/bmm-2016-0090.
doi: 10.2217/bmm-2016-0090 pmid: 27611762 |
| [36] |
Chakravarthy M, Parsons S, Lassman ME , et al. Effects of 13-hour hyperglucagonemia on energy expenditure and hepatic glucose production in humans[J]. Diabetes, 2017,66(1):36-44. DOI: 10.2337/db16-0746.
doi: 10.2337/db16-0746 pmid: 27999106 |
| [37] |
Rizza RA . Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes:implications for therapy[J]. Diabetes, 2010,59(11):2697-2707. DOI: 10.2337/db10-1032.
doi: 10.2337/db10-1032 pmid: 20705776 |
| [38] |
Wang XL, Ye F, Li J , et al. Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus[J]. Saudi Med J, 2016,37(1):48-54. DOI: 10.15537/smj.2016. 1.12035.
doi: 10.15537/smj.2016. 1.12035 pmid: 4724679 |
| [39] |
Paterson MA, Smart CE, Lopez PE , et al. Increasing the protein quantity in a meal results in dose-dependent effects on postprandial glucose levels in individuals with type 1 diabetes mellitus[J]. Diabet Med, 2017,34(6):851-854. DOI: 10.1111/dme.13347.
doi: 10.1111/dme.13347 pmid: 28257160 |
| [40] |
Harp JB, Yancopoulos GD, Gromada J . Glucagon orchestrates stress-induced hyperglycaemia[J]. Diabetes Obes Metab, 2016,18(7):648-653. DOI: 10.1111/dom. 12668.
doi: 10.1111/dom. 12668 |
| [41] |
Chia CW, Odetunde JO, Kim W , et al. GIP contributes to islet trihormonal abnormalities in type 2 diabetes[J]. J Clin Endocrinol Metab, 2014,99(7):2477-2485. DOI: 10.1210/jc.2013-3994.
doi: 10.1210/jc.2013-3994 pmid: 24712564 |
| [42] |
Godoy-Matos AF . The role of glucagon on type 2 diabetes at a glance[J]. Diabetol Metab Syndr, 2014,6(1):91-95.DOI: 10.1186/1758-5996-6-91.
doi: 10.1186/1758-5996-6-91 pmid: 4148933 |
| [43] |
Miller RA, Chu Q, Xie J , et al. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP[J]. Nature, 2013,494(7436):256-260. DOI: 10.1038/nature11808.
doi: 10.1038/nature11808 pmid: 23292513 |
| [44] |
Konopka AR, Esponda RR, Robinson MM , et al. Hyperglucagonemia mitigates the effect of metformin on glucose production in prediabetes[J]. Cell Rep, 2016,15(7):1394-1400. DOI: 10.1016/j.celrep.2016.04.024.
doi: 10.1016/j.celrep.2016.04.024 pmid: 27160898 |
| [45] |
Cooperberg BA, Cryer PE . Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans[J]. Diabetes Care, 2009,32(12):2275-2280. DOI: 10.2337/dc09-0798.
doi: 10.2337/dc09-0798 pmid: 19729529 |
| [46] |
?sterg?rd T, Degn KB, Gall MA , et al. The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency[J]. J Clin Endocrinol Metab, 2004,89(1):297-302. DOI: 10.1210/jc.2003-031011.
doi: 10.1210/jc.2003-031011 pmid: 14715864 |
| [47] |
Ahrén B, Foley JE, Ferrannini E , et al. Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy[J]. Diabetes Care, 2010,33(4):730-732. DOI: 10.2337/dc09-1867.
doi: 10.2337/dc09-1867 pmid: 2845014 |
| [48] |
Zheng MY, Yang JH, Shan CY , et al. Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients:a preliminary report[J]. Cardiovasc Diabetol, 2013,12(1):73-80. DOI: 10.1186/1475-2840-12-73.
doi: 10.1186/1475-2840-12-73 pmid: 23642288 |
| [49] |
Kratzner R, Frohlich F, Lepler K , et al. A peroxisome proliferator-activated receptor-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription[J]. Mol Pharmacol, 2007,73(2):509-517. DOI: 10.1124/mol.107.035568.
doi: 10.1124/mol.107.035568 pmid: 17962386 |
| [50] |
Tostes GC, Cunha MR, Fukui RT , et al. Effects of nateglinide and rosiglitazone on pancreatic alpha-and beta-cells,GLP-1 secretion and inflammatory markers in patients with type 2 diabetes:randomized crossover clinical study[J]. Diabetol Metab Syndr, 2016,8(1):1-9. DOI: 10.1186/s13098-015-0120-6.
doi: 10.1186/s13098-015-0120-6 pmid: 4700605 |
| [51] |
Farmer TD, Jenkins EC , O’Brien TP,et al. Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp[J]. Am J Physiol Endocrinol Metab, 2015,308(3):E206-E222. DOI: 10.1152/ajpendo.00406.2014.
doi: 10.1152/ajpendo.00406.2014 pmid: 25516552 |
| [52] |
Unger RH, Cherrington AD . Glucagonocentric restructuring of diabetes:a pathophysiologic and therapeutic makeover[J]. J Clin Invest, 2012,122(1):4-12. DOI: 10.1172/JCI60016.
doi: 10.1172/JCI60016 pmid: 22214853 |
| [53] |
Adeghate E, Lotfy M, Kalasz H , et al. Recent progress in the use of glucagon and glucagon receptor antagonists in the treatment of diabetes mellitus[J]. Open Med Chem J, 2014,8(1):28-35. DOI: 10.2174/1874104501408010028.
doi: 10.2174/1874104501408010028 pmid: 25674162 |
| [54] |
Lefèbvre PJ, Paquot N, Scheen AJ . Inhibiting or antagonizing glucagon:making progress in diabetes care[J]. Diabetes Obes Metab, 2015,17(8):720-725. DOI: 10.1111/dom.12480.
doi: 10.1111/dom.12480 pmid: 25924114 |
| [55] |
Renukuntla VS, Ramchandani N, Trast J , et al. Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm[J]. J Diabetes Sci Technol, 2014,8(5):1011-1017. DOI: 10.1177/1932296814542153.
doi: 10.1177/1932296814542153 |
| [56] |
Bonner C, Kerr-Conte J, Gmyr V , et al. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion[J]. Nat Med, 2015,21(5):512-517.DOI: 10.1038/nm.3828.
doi: 10.1038/nm.3828 pmid: 25894829 |
| [1] | GONG Ge,YIN Jian,YANG Xiang,ZHANG Xinghu,ZHANG Yuan,WAN Wenhui. Long Non-coding RNA Act as Regulators of Autophagy in Disease Treatment [J]. Acta Academiae Medicinae Sinica, 2018, 40(6): 827-831. |
| [2] | LIU Jia,WANG Ying,ZHANG Bo. Advances in Diagnosis and Treatment of Thyroid Cancer in Children and Adolescents [J]. Acta Academiae Medicinae Sinica, 2018, 40(6): 838-842. |
| [3] | WU Xin,LI Binglu,ZHENG Chaoji,HE Xiaodong. Diagnosis and Treatment of Epithelioid Hemangioendothelioma [J]. Acta Academiae Medicinae Sinica, 2018, 40(5): 667-672. |
| [4] | LIU Yang,YAO Yong,ZHU Huijuan. Research Advances in Hypothalamic-pituitary Dysfunction Related to Traumatic Brain Injury [J]. Acta Academiae Medicinae Sinica, 2018, 40(5): 699-704. |
| [5] | Jie BAI, Zhihong WANG. Diagnosis and Treatment of Acute Intermittent Porphyria [J]. Acta Academiae Medicinae Sinica, 2017, 39(6): 836-840. |
| [6] | Fangfang XU, Nan WANG, Gangqiang LI, Wenfang GUO, Caifeng YANG, Dehu LIU. Establishment and Assessment of Mice Models of Type 2 Diabetes Mellitus [J]. Acta Academiae Medicinae Sinica, 2017, 39(3): 324-329. |
| [7] | Bo ZHOU, Hui HUANG, Zhengang XU, Yuehuang WU, Xiaolei WANG. Long-term Outcomes of cN0 Papillary Thyroid Carcinoma without Elective Central Compartment Neck Dissection [J]. Acta Academiae Medicinae Sinica, 2017, 39(3): 383-388. |
| [8] | Ruiqi ZHUGE, Rong ZHOU, Xinhai NI. Progress in Molecular Genetic Study of Mitochondrial Cardiomyopathy [J]. Acta Academiae Medicinae Sinica, 2017, 39(3): 438-444. |
| [9] | Tao WANG, Beibei SU, Dawei HAN, Anli TONG, Jian LI, Yuehua LIU, Hongzhong JIN, Kai FANG. Clinical Analysis of 122 Cases of Langerhans Cell Histiocytosis [J]. Acta Academiae Medicinae Sinica, 2017, 39(2): 206-210. |
| [10] | Yi-xiao ZHAO, Hong LÜ. Autoimmune Pancreatitis:Typing,Diagnosis,and Treatment [J]. Acta Academiae Medicinae Sinica, 2016, 38(6): 731-734. |
| [11] | Wei-yu MAO, Hui YOU, Bing XING, Hui-juan ZHU, Feng FENG. Advances in Evaluation of Cognitive Impairment in Patients with Cushing’s Disease [J]. Acta Academiae Medicinae Sinica, 2016, 38(6): 735-738. |
| [12] | Qing SUN, Xiao-chun LIANG. Advances in the Relationship between Adipokines and β-cell Failure in Type 2 Diabetes Mellitus [J]. Acta Academiae Medicinae Sinica, 2016, 38(5): 601-606. |
| [13] | Ting-ting XIA, Zhi-bo XU, Xian-zhong LIU, Wei-quan TONG, Li-ting ZHANG, Fang CHEN, Hui-reng WANG. New Advances in the Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis [J]. Acta Academiae Medicinae Sinica, 2016, 38(5): 611-616. |
| [14] | Guo-tao MA, Qi MIAO, Xing-rong LIU, Chao-ji ZHANG, Yue-hong ZHENG, Jiang SHAO, Ning-hai CHENG, Shun-da DU, Jian-zhou LIU, Chao JIANG. Surgical Treatment Strategies of Intravenous Leiomyomatosis with Right Cardiac Cavities Extension [J]. Acta Academiae Medicinae Sinica, 2016, 38(4): 438-443. |
| [15] | Yao-jie LIANG, Jun-zhong SUN. Research Advances in Bacteria-based Microrobot [J]. Acta Academiae Medicinae Sinica, 2016, 38(4): 453-457. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
